UK university spinouts attracted £1.56 billion of investment in the first half of 2026, but funding for new ventures collapsed by more than two-thirds, according to research published by IP Group PLC (LSE:IPO) and its fund management subsidiary Parkwalk. Investment climbed 38.2% from the second half of 2025 to its second-highest half-year level in a decade, approaching the £1.58 billion record set in 2021.
IP Group PLC (LSE:IPO) has invested £4 million in a £36 million funding round for portfolio company Microbiotica, backing the development of a potential new treatment for ulcerative colitis. The Series C financing, led by British Business Bank, will support the progression of Microbiotica's lead drug candidate, MB310, into Phase 2 clinical trials following encouraging early-stage results.
IP Group PLC (LSE:IPO) has led a £4 million funding round in Matter Machine, a University of Liverpool spin-out using artificial intelligence to accelerate the discovery of new materials. The oversubscribed pre-Series A financing also attracted backing from Northern Gritstone, Norrsken Evolve, LYVA Labs and other investors, with proceeds earmarked for expanding the company's team, developing its technology and building commercial partnerships.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
Kyle P. Smith NewEdge Wealth LLC | 6,450 | $363,457.5 | $313,695.75 | -$49,761.75 | -13.69% |
Richard Slavik Newbridge Financial Services Group Inc. | 1,000 | $41,880 | $48,530 | $6,650 | 15.88% |
Sima Elimelech Activest Wealth Management | 45 | $1,884.6 | $2,168.55 | $283.95 | 15.07% |
Joel A. Schreiber SFI Advisors LLC | 20,468 | $743,664.89 | $988,502.06 | $244,837.17 | 32.92% |
Richard A. Flora Key Client Fiduciary Advisors LLC | 3,954 | $222,457.28 | $192,737.73 | -$29,719.55 | -13.36% |
| ARCA Exchange | US Country |
This fund is designed to mirror the performance, before fees and expenses, of a specific index that tracks companies recently having completed an IPO and are listed on a U.S. exchange. By aiming to closely follow the price and yield performance of the index, the fund represents a focused investment strategy, targeting a specific portion of the market. This strategy involves investing at least 80% of its total assets in securities that are part of the index. It is important to note that the fund is non-diversified, meaning it may invest a larger portion of its assets in fewer securities, potentially increasing volatility and risk.
The primary offering of this fund includes: